GENOMIC STABILITY AND AGING IN YEAST
酵母的基因组稳定性和老化
基本信息
- 批准号:6372312
- 负责人:
- 金额:$ 26.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Werner's Syndrome (WS) is a genetic disease characterized by premature aging and chromosomal instability. The gene responsible for WS (WRN) is similar to the SGS1 gene of yeast and, like WS, SGS1 mutants display premature aging and genomic instability. Both WRN and SGS1 encode 160 kDa proteins belonging to the RecQ family of DNA helicases. Because WRN and SGS1 are likely to function in identical genetic pathways, a search for mutations that interact with SGS1 should uncover genes that control cellular aging and genome stability. Genetic experiments are proposed to identify and characterize genes that interact directly and indirectly with SGS1, and biochemical experiments will be used to determine the function of the encoded gene products. An SGS1 synthetic-lethal mutant screen has been conducted to identify mutations that cause the cell to require SGS1 for viability. The genes responsible for these mutations (SLX genes) are likely to act in genetic pathways that are parallel to SGS1. Some of the SLX genes have been cloned and found to encode novel proteins with conserved human homologs. The complete set of SLX genes will be cloned and all SLX mutants will be characterized for effects on yeast aging and genomic stability. The expression pattern, cellular localization, and enzymatic activity of the SLX proteins will be determined. These results will be confirmed by similar studies of the SLX1 gene in human cells. To identify genes that interact directly with SGS1, we have isolated a set of novel conditional-lethal alleles of SGS1. Extragenic suppressors of these alleles are expected to act directly in the SGS1 pathway. Suppressor strains will be isolated and affected genes will be cloned. Additional genes in this pathway will be identified by searching for mutations that show SGS1-specific phenotypes and by performing a synthetic-lethal screen with SLX mutants. To determine the biochemical function of the SLX and SGS1 proteins, they will be purified from yeast in their native form. These purified proteins will be assayed for enzymatic activities involved in DNA metabolism. Stably-assoicated proteins that co-purify with the SLX and SGS1 proteins will be subjected to amino acid sequencing, molecular cloning and reverse genetics to identify their function in controlling cellular aging and genomic stability.
Werner综合征(WS)是一种以过早衰老和染色体不稳定为特征的遗传性疾病。 负责WS的基因(WRN)与酵母的SGS1基因相似,并且与WS一样,SGS1突变体显示出过早衰老和基因组不稳定性。 WRN和SGS1都编码属于RecQ DNA解旋酶家族的160 kDa蛋白。 由于WRN和SGS1可能在相同的遗传途径中发挥作用,因此对与SGS1相互作用的突变的研究应该会发现控制细胞衰老和基因组稳定性的基因。 遗传学实验被提出来鉴定和表征与SGS1直接和间接相互作用的基因,并且生化实验将被用于确定编码基因产物的功能。已进行SGS1合成致死突变体筛选,以鉴定导致细胞需要SGS1才能生存的突变。 负责这些突变的基因(SLX基因)可能在与SGS1平行的遗传途径中起作用。一些SLX基因已被克隆并发现编码具有保守人类同源物的新蛋白质。 将克隆完整的SLX基因组,并对所有SLX突变体进行表征,以确定其对酵母老化和基因组稳定性的影响。 将确定SLX蛋白的表达模式、细胞定位和酶活性。 这些结果将通过对人类细胞中SLX1基因的类似研究得到证实。 为了鉴定与SGS1直接相互作用的基因,我们分离了一组新的SGS1条件致死等位基因。 预期这些等位基因的基因外抑制子直接作用于SGS1途径。 将分离抑制菌株并克隆受影响的基因。 该途径中的其他基因将通过搜索显示SGS1特异性表型的突变和通过使用SLX突变体进行合成致死筛选来鉴定。 为了确定SLX和SGS1蛋白的生化功能,将从酵母中以其天然形式纯化它们。 将测定这些纯化蛋白质的DNA代谢相关酶活性。 与SLX和SGS1蛋白共纯化的稳定相关蛋白将进行氨基酸测序、分子克隆和反向遗传学,以鉴定它们在控制细胞衰老和基因组稳定性中的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN J. BRILL其他文献
STEVEN J. BRILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN J. BRILL', 18)}}的其他基金
Genomic Stability and RecQ DNA Helicases in Yeast
酵母中的基因组稳定性和 RecQ DNA 解旋酶
- 批准号:
7035787 - 财政年份:1999
- 资助金额:
$ 26.8万 - 项目类别:
相似海外基金
Role of RECQL5 in regulation of lipid metabolism in novel Werner's syndrome model mice
RECQL5在新型维尔纳综合征模型小鼠脂质代谢调节中的作用
- 批准号:
20K16538 - 财政年份:2020
- 资助金额:
$ 26.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The research on the clinical characters of malignant neoplasm andthe origin of the causative-gene mutation in Werner's syndrome.
维尔纳综合征恶性肿瘤临床特征及致病基因突变起源的研究。
- 批准号:
21590755 - 财政年份:2009
- 资助金额:
$ 26.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Werner's Syndrome Protein in Cigarette Smoke-Induced Cellular Senescence
维尔纳综合征蛋白在香烟烟雾诱导的细胞衰老中的作用
- 批准号:
7586204 - 财政年份:2008
- 资助金额:
$ 26.8万 - 项目类别:
Role of Werner's Syndrome Protein in Cigarette Smoke-Induced Cellular Senescence
维尔纳综合征蛋白在香烟烟雾诱导的细胞衰老中的作用
- 批准号:
7779961 - 财政年份:2008
- 资助金额:
$ 26.8万 - 项目类别:
Role of Werner's Syndrome Protein in Cigarette Smoke-Induced Cellular Senescence
维尔纳综合征蛋白在香烟烟雾诱导的细胞衰老中的作用
- 批准号:
7468711 - 财政年份:2008
- 资助金额:
$ 26.8万 - 项目类别:
WERNER'S SYNDROME ENDONUCLEASE / PROLIFERATING CELL NUCLEAR ANTIGEN
维尔纳综合征核酸内切酶/增殖细胞核抗原
- 批准号:
6976385 - 财政年份:2004
- 资助金额:
$ 26.8万 - 项目类别:
Analysis of telomere metabolism in Werner's syndrome patients.
维尔纳综合征患者端粒代谢分析。
- 批准号:
15590328 - 财政年份:2003
- 资助金额:
$ 26.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)